HARP
Harpoon Therapeutics Inc
Halal Rating :
Last Price
$23.01
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company developing novel T cell engagers. The company focuses on treating cancer patients through its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform technology. Their pipeline includes multiple drug candidates targeting various cancer types.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $4.45m | $18.63m | - | $2.05m | 0.00% | 10.98% |
| June 30, 2023 | $20.22m | $19.29m | - | $1.56m | 0.00% | 8.09% |
| March 31, 2023 | $8.58m | $19.49m | - | $138000.0 | 0.00% | 0.71% |
Company Impact
Help us evaluate Harpoon Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.